Cargando…
Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis
PURPOSE: To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560560/ https://www.ncbi.nlm.nih.gov/pubmed/36249695 http://dx.doi.org/10.1016/j.xops.2022.100152 |
_version_ | 1784807776302661632 |
---|---|
author | Aisu, Nao Miyake, Masahiro Hosoda, Yoshikatsu Mori, Yuki Takahashi, Ayako Muraoka, Yuki Ueda-Arakawa, Naoko Miyata, Manabu Oishi, Akio Tamura, Hiroshi Ooto, Sotaro Yamashiro, Kenji Tsujikawa, Akitaka |
author_facet | Aisu, Nao Miyake, Masahiro Hosoda, Yoshikatsu Mori, Yuki Takahashi, Ayako Muraoka, Yuki Ueda-Arakawa, Naoko Miyata, Manabu Oishi, Akio Tamura, Hiroshi Ooto, Sotaro Yamashiro, Kenji Tsujikawa, Akitaka |
author_sort | Aisu, Nao |
collection | PubMed |
description | PURPOSE: To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2007 to June 2017 and followed up for at least 2 years. Patients who underwent ocular treatment other than cataract surgery before the beginning of recruitment and those who had macular neovascularization at baseline were excluded. METHODS: All patients underwent a comprehensive ophthalmic evaluation, including measurements of best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, color fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and spectral-domain OCT. An inverse probability of treatment weighting (IPTW) methodology was applied to balance 18 baseline characteristics between patients who received rf-PDT (rf-PDT group) and those who did not receive treatment (controls). Inverse probability of treatment weighting survival analysis and regression were performed. MAIN OUTCOME MEASURES: The proportion of patients whose BCVA at 24 months was the same or improved compared with the baseline visual acuity (VA) (VA maintenance rate). RESULTS: A total of 155 eyes (rf-PDT group: 74; controls: 81) were analyzed. The patients’ backgrounds were well balanced after IPTW with standardized differences of < 0.10. An IPTW regression analysis revealed that the VA maintenance rate was significantly higher in the rf-PDT group than in the controls (93.6% vs. 70.9%, P < 0.001, 12 months; 85.7% vs. 69.8%, P = 0.019, 24 months). The rf-PDT group tended to show better VA improvement, but was not statistically significant (–0.06 vs. –0.008, P = 0.07, 12 months; –0.06 vs. –0.03, P = 0.32, 24 months). An IPTW Cox regression showed a significantly higher rate of complete SRD remission in the rf-PDT group (hazard ratio, 5.05; 95% confidence interval, 3.24–7.89; P < 0.001). CONCLUSIONS: The study suggests the beneficial effect of rf-PDT for cCSC for both VA maintenance and higher proportion of complete SRD remission in the clinical setting. |
format | Online Article Text |
id | pubmed-9560560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95605602022-10-14 Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis Aisu, Nao Miyake, Masahiro Hosoda, Yoshikatsu Mori, Yuki Takahashi, Ayako Muraoka, Yuki Ueda-Arakawa, Naoko Miyata, Manabu Oishi, Akio Tamura, Hiroshi Ooto, Sotaro Yamashiro, Kenji Tsujikawa, Akitaka Ophthalmol Sci Original Article PURPOSE: To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2007 to June 2017 and followed up for at least 2 years. Patients who underwent ocular treatment other than cataract surgery before the beginning of recruitment and those who had macular neovascularization at baseline were excluded. METHODS: All patients underwent a comprehensive ophthalmic evaluation, including measurements of best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, color fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and spectral-domain OCT. An inverse probability of treatment weighting (IPTW) methodology was applied to balance 18 baseline characteristics between patients who received rf-PDT (rf-PDT group) and those who did not receive treatment (controls). Inverse probability of treatment weighting survival analysis and regression were performed. MAIN OUTCOME MEASURES: The proportion of patients whose BCVA at 24 months was the same or improved compared with the baseline visual acuity (VA) (VA maintenance rate). RESULTS: A total of 155 eyes (rf-PDT group: 74; controls: 81) were analyzed. The patients’ backgrounds were well balanced after IPTW with standardized differences of < 0.10. An IPTW regression analysis revealed that the VA maintenance rate was significantly higher in the rf-PDT group than in the controls (93.6% vs. 70.9%, P < 0.001, 12 months; 85.7% vs. 69.8%, P = 0.019, 24 months). The rf-PDT group tended to show better VA improvement, but was not statistically significant (–0.06 vs. –0.008, P = 0.07, 12 months; –0.06 vs. –0.03, P = 0.32, 24 months). An IPTW Cox regression showed a significantly higher rate of complete SRD remission in the rf-PDT group (hazard ratio, 5.05; 95% confidence interval, 3.24–7.89; P < 0.001). CONCLUSIONS: The study suggests the beneficial effect of rf-PDT for cCSC for both VA maintenance and higher proportion of complete SRD remission in the clinical setting. Elsevier 2022-04-06 /pmc/articles/PMC9560560/ /pubmed/36249695 http://dx.doi.org/10.1016/j.xops.2022.100152 Text en © 2022 by the American Academy of Ophthalmology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Aisu, Nao Miyake, Masahiro Hosoda, Yoshikatsu Mori, Yuki Takahashi, Ayako Muraoka, Yuki Ueda-Arakawa, Naoko Miyata, Manabu Oishi, Akio Tamura, Hiroshi Ooto, Sotaro Yamashiro, Kenji Tsujikawa, Akitaka Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis |
title | Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis |
title_full | Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis |
title_fullStr | Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis |
title_full_unstemmed | Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis |
title_short | Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis |
title_sort | effectiveness of reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy: a propensity score analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560560/ https://www.ncbi.nlm.nih.gov/pubmed/36249695 http://dx.doi.org/10.1016/j.xops.2022.100152 |
work_keys_str_mv | AT aisunao effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT miyakemasahiro effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT hosodayoshikatsu effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT moriyuki effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT takahashiayako effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT muraokayuki effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT uedaarakawanaoko effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT miyatamanabu effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT oishiakio effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT tamurahiroshi effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT ootosotaro effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT yamashirokenji effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis AT tsujikawaakitaka effectivenessofreducedfluencephotodynamictherapyforchroniccentralserouschorioretinopathyapropensityscoreanalysis |